THE PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN PATIENTS WITH NEOPLASTIC DISEASE

被引：16
|
作者：
BRYSON, SM
MCGOVERN, EM
KELMAN, AW
WHITE, K
ADDIS, GJ
WHITING, B
机构：
[1] STOBHILL GEN HOSP,DEPT NUCL MED,GLASGOW G21 3UW,SCOTLAND
[2] STOBHILL GEN HOSP,DEPT PHARM,GLASGOW G21 3UW,SCOTLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 19卷 / 06期
关键词：
D O I：
10.1111/j.1365-2125.1985.tb02711.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：757 / 766
页数：10
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF HIGH-DOSE BCNU IN MAN
    WORKMAN, P
    MBIDDE, E
    SELBY, P
    MCELWAIN, TJ
    BLOOM, HJG
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 129 - 129
  • [42] HIGH-DOSE BISANTRENE - PHARMACOKINETICS IN HUMAN
    MARTY, M
    GOURMEL, B
    LEFEBVRE, B
    ISNARD, F
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 122 - 122
  • [43] CLINICAL PHARMACOKINETICS OF HIGH-DOSE DTIC
    BUESA, JM
    URRECHAGA, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) : 475 - 479
  • [44] PHARMACOKINETICS OF HIGH-DOSE METHYLPREDNISOLONE IN CHILDREN
    ITO, S
    KUSUNOKI, Y
    OKA, T
    ITO, Y
    OKUNO, A
    YOSHIOKA, H
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1992, 19 (2-3): : 99 - 105
  • [45] PHARMACOKINETICS OF HIGH-DOSE BUSULFAN IN CHILDREN
    VASSAL, G
    GOUYETTE, A
    HARTMANN, O
    PICO, JL
    LEMERLE, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (06) : 386 - 390
  • [46] PHARMACOKINETICS OF CEFOPERAZONE IN PATIENTS WITH NEOPLASTIC DISEASE
    MAKSYMIUK, AW
    LEBLANC, BM
    BROWN, NS
    HO, DH
    BODEY, GP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) : 1037 - 1041
  • [47] EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN IN A SINGLE-BLIND STUDY
    CHEVALLIER, B
    EUROPEAN JOURNAL OF CANCER, 1990, 26 : S33 - S36
  • [48] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE
    AAPRO, MS
    PLEZIA, PM
    ALBERTS, DS
    GRAHAM, V
    JONES, SE
    SURWIT, EA
    MOON, TE
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 466 - 471
  • [49] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
  • [50] PHARMACOKINETIC STUDIES OF HIGH-DOSE METOCLOPRAMIDE WITH AND WITHOUT FORCED DIURESIS
    ELL, C
    BRAUN, J
    KONIG, HJ
    DOMSCHKE, S
    DOMSCHKE, W
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (12): : 572 - 574
12345